John B Gurdon and Shinya Yamanaka share 2012 Nobel Prize for Medicine

08 Oct 2012

1

The 2012 Nobel Prize in Physiology or Medicine was awarded jointly to John B Gurdon and Shinya Yamanaka "for the discovery that mature cells can be reprogrammed to become pluripotent"

Sir John B. Gurdon and Shinya Yamanaka''The Nobel Prize recognises two scientists who discovered that mature, specialised cells can be reprogrammed to become immature cells capable of developing into all tissues of the body. Their findings have revolutionised our understanding of how cells and organisms develop,'' the Nobel Prize committee said in its release.

Prof Gurdon's work in frogs demonstrated that adult cells could be introduced into an egg and that it could still form into a fully functional tadpole and frog. This fundamental biology discovery overturned years of previous theory and laid the foundation for current exciting research in induced pluripotent stem cells.

John B. Gurdon discovered in 1962 that the specialisation of cells is reversible. In a classic experiment, he replaced the immature cell nucleus in an egg cell of a frog with the nucleus from a mature intestinal cell. This modified egg cell developed into a normal tadpole. The DNA of the mature cell still had all the information needed to develop all cells in the frog.

Shinya Yamanaka discovered more than 40 years later, in 2006, how intact mature cells in mice could be reprogrammed to become immature stem cells. Surprisingly, by introducing only a few genes, he could reprogram mature cells to become pluripotent stem cells, i.e. immature cells that are able to develop into all types of cells in the body.

These groundbreaking discoveries have completely changed our view of the development and cellular specialisation. We now understand that the mature cell does not have to be confined forever to its specialised state. Textbooks have been rewritten and new research fields have been established. By reprogramming human cells, scientists have created new opportunities to study diseases and develop methods for diagnosis and therapy.

Latest articles

Nigeria and South Africa drive global stablecoin demand surge, study finds

Nigeria and South Africa drive global stablecoin demand surge, study finds

Cisco and Qunnect test real-world quantum network over New York fiber cables

Cisco and Qunnect test real-world quantum network over New York fiber cables

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

The $250 billion pivot: how 2026 became the year AI paid the rent

The $250 billion pivot: how 2026 became the year AI paid the rent

Sweden fines SBB over accounting violations, raising scrutiny on property sector

Sweden fines SBB over accounting violations, raising scrutiny on property sector

Ukraine-Russia peace talks enter second day in Geneva amid pressure concerns

Ukraine-Russia peace talks enter second day in Geneva amid pressure concerns

India asks university to exit AI summit after robot’s origin questioned

India asks university to exit AI summit after robot’s origin questioned

Redmond’s global reach: Microsoft on pace for $50 billion AI investment in the Global South

Redmond’s global reach: Microsoft on pace for $50 billion AI investment in the Global South

Data centres explore funding uranium projects as AI power demand surges, says NexGen CEO

Data centres explore funding uranium projects as AI power demand surges, says NexGen CEO